References
- Estey E, Dohner H. Acute myeloid leukaemia. Lancet. 2006;368(9550):1894–907. doi:https://doi.org/10.1016/S0140-6736(06)69780-8
- Lichtman MA. A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7 + 3. Blood Cells Mol Dis. 2013;50(2):119–30. doi:https://doi.org/10.1016/j.bcmd.2012.10.005
- de The H. Differentiation therapy revisited. Nat Rev Cancer. 2018;18:117–27. doi:https://doi.org/10.1038/nrc.2017.103
- Walasek A. The new perspectives of targeted therapy in acute myeloid leukemia. Adv Clin Exp Med. 2019;28(2):271–6. doi:https://doi.org/10.17219/acem/81610
- Martino OD, Welch JS. Retinoic acid receptors in acute myeloid Leukemia therapy. Cancers (Basel). 2019;11(12):1915. doi:https://doi.org/10.3390/cancers11121915
- Rego EM, De Santis GC. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment. Mediterr J Hematol Infect Dis. 2011;3(1):e2011048. doi:https://doi.org/10.4084/mjhid.2011.048
- Demain AL, Vaishnav P. Natural products for cancer chemotherapy. Microb Biotechnol. 2011;4(6):687–99. doi:https://doi.org/10.1111/j.1751-7915.2010.00221.x
- Yuan R, Hou Y, Sun W, Yu J, Liu X, Niu Y, Lu J-J, Chen X. Natural products to prevent drug resistance in cancer chemotherapy: a review. Ann NY Acad Sci. 2017;1401(1):19–27. doi:https://doi.org/10.1111/nyas.13387
- Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015;33(8):1582–614. doi:https://doi.org/10.1016/j.biotechadv.2015.08.001
- Chirkin E, Atkatlian W, Poree FH. The Securinega alkaloids. Alkaloids Chem Biol. 2015;74:1–120. doi:https://doi.org/10.1016/bs.alkal.2014.11.001
- Weinreb SM. Total synthesis of the Securinega alkaloids. Nat Prod Rep. 2009;26(6):758–75. doi:https://doi.org/10.1039/b902265a
- Copperman R, Copperman G, Der Marderosian A. From Asia securinine–a central nervous stimulant is used in treatment of amytrophic lateral sclerosis. Pa Med. 1973;76:36–41.
- Buravtseva GR. Result of application of securinine in acute poliomyelitis. Farmakol Toksikol. 1958;21:7–12.
- Treatment of chronic aplastic anemia with securinine–analysis of 123 cases. Zhonghua Nei Ke Za Zhi. 1983;22:764–6.
- Beutler JA, Karbon EW, Brubaker AN, Malik R, Curtis DR, Enna SJ. Securinine alkaloids: a new class of GABA receptor antagonist. Brain Res. 1985;330(1):135–40. doi:https://doi.org/10.1016/0006-8993(85)90014-9
- Beha E, Jung A, Wiesner J, Rimpler H, Lanzer M, Heinrich M. Antimalarial activity of extracts of Abutilon grandiflorum G. Don - a traditional Tanzanian medicinal plant. Phytother Res. 2004;18(3):236–40. doi:https://doi.org/10.1002/ptr.1393
- Mensah JL, Lagarde I, Ceschin C, Michelb G, Gleye J, Fouraste I. Antibacterial activity of the leaves of Phyllanthus discoideus. J Ethnopharmacol. 1990;28(1):129–33. doi:https://doi.org/10.1016/0378-8741(90)90069-6
- Tatematsu H, Mori M, Yang T-H, Chang J-J, Lee TT-Y, Lee K-H. Cytotoxic principles of Securinega virosa: virosecurinine and viroallosecurinine and related derivatives. J Pharm Sci. 1991;80(4):325–7. doi:https://doi.org/10.1002/jps.2600800408
- Dong NZ, Gu ZL, Chou WH, Kwok CY. Securinine induced apoptosis in human leukemia HL-60 cells. Zhongguo Yao Li Xue Bao. 1999;20:267–70.
- Li M, Han S, Zhang G, Wang Y, Ji Z. Antiproliferative activity and apoptosis-inducing mechanism of L-securinine on human breast cancer MCF-7 cells. Pharmazie. 2014;69:217–23.
- Zhang D, Liu H, Yang B, Hu J, Cheng Y. L-securinine inhibits cell growth and metastasis of human androgen-independent prostate cancer DU145 cells via regulating mitochondrial and AGTR1/MEK/ERK/STAT3/PAX2 apoptotic pathways. Biosci Rep. 2019;39(5):BSR20190469. doi:https://doi.org/10.1042/BSR20190469
- Gupta K, Chakrabarti A, Rana S, Ramdeo R, Roth BL, Agarwal ML, Tse W, Agarwal MK, Wald DN. Securinine, a myeloid differentiation agent with therapeutic potential for AML. PLoS One. 2011;6(6):e21203. doi:https://doi.org/10.1371/journal.pone.0021203
- Drexler HG, Quentmeier H, MacLeod RA, Uphoff CC, Hu ZB. Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. Leuk Res. 1995;19(10):681–91. doi:https://doi.org/10.1016/0145-2126(95)00036-N
- Khanna-Gupta A, Kolibaba K, Zibello TA, Berliner N. Berliner N: NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood. 1994;84(1):294–302. doi:https://doi.org/10.1182/blood.V84.1.294.294
- Guo Q, Zhang L, Li F, Jiang G. The plasticity and potential of leukemia cell lines to differentiate into dendritic cells. Oncol Lett. 2012;4(4):595–600. doi:https://doi.org/10.3892/ol.2012.821
- Chen A, Licht JD, Wu Y, Hellinger N, Scher W, Waxman S. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents. Blood. 1994;84(7):2122–9. doi:https://doi.org/10.1182/blood.V84.7.2122.bloodjournal8472122
- Lee K-H, Chang M-Y, Ahn J-I, Yu D-H, Jung S-S, Choi J-H, Noh Y-H, Lee Y-S, Ahn M-J. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem Biophys Res Commun. 2002;296(5):1125–33. doi:https://doi.org/10.1016/S0006-291X(02)02043-0
- Soundararajan R, Prabha P, Rai U, Dixit A. Antileukemic Potential of Momordica charantia seed extracts on human myeloid leukemic HL60 Cells. Evid Based Complement Alternat Med. 2012;2012:1–10. doi:https://doi.org/10.1155/2012/732404
- Yedjou CG, Moore P, Tchounwou PB. Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment. IJERPH. 2006;3(2):136–40. doi:https://doi.org/10.3390/ijerph.2006030017
- Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A. 1980;77(5):2936–40. doi:https://doi.org/10.1073/pnas.77.5.2936
- Yong WK, Abd Malek SN. Xanthohumol induces growth inhibition and apoptosis in ca ski human cervical cancer cells. Evid Based Complement Alternat Med. 2015;2015:1–10. doi:https://doi.org/10.1155/2015/921306
- Sharma S, Singh RL, Kakkar P. Modulation of Bax/Bcl-2 and caspases by probiotics during acetaminophen induced apoptosis in primary hepatocytes. Food Chem Toxicol. 2011;49(4):770–9. doi:https://doi.org/10.1016/j.fct.2010.11.041
- Marchal JA, Rodriguez-Serrano F, Campos J, Madeddu R, Boulaiz H. Differentiation: an encouraging approach to anticancer therapy. Ital J Anat Embryol. 2006;111:45–64.
- Fridlender M, Kapulnik Y, Koltai H. Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci. 2015;6:799. doi:https://doi.org/10.3389/fpls.2015.00799
- Jaudan A, Sharma S, Malek SNA, Dixit A. Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action. PLoS One. 2018;13(2):e0191523. doi:https://doi.org/10.1371/journal.pone.0191523
- Jadaun A, Sharma S, Verma R, Dixit A. Pinostrobin inhibits proliferation and induces apoptosis in cancer stem-like cells through a reactive oxygen species-dependent mechanism. RSC Adv. 2019;9(21):12097–109. doi:https://doi.org/10.1039/C8RA08380K
- Huang Q, Wang L, Ran Q, Wang J, Wang C, He H, Li L, Qi H. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells. DDDT. 2019;13:1927–40. doi:https://doi.org/10.2147/DDDT.S189969
- Li D, Wang Z, Chen H, Wang J, Zheng Q, Shang J, Li J. Isoliquiritigenin induces monocytic differentiation of HL-60 cells. Free Radic Biol Med. 2009;46(6):731–6. doi:https://doi.org/10.1016/j.freeradbiomed.2008.11.011
- Han S, Zhang GANG, Li M, Chen D, Wang YING, Ye W, Ji Z. L-securinine induces apoptosis in the human promyelocytic leukemia cell line HL-60 and influences the expression of genes involved in the PI3K/AKT/mTOR signaling pathway. Oncol Rep. 2014;31(5):2245–51. doi:https://doi.org/10.3892/or.2014.3101
- Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 1987;70(5):1233–44. doi:https://doi.org/10.1182/blood.V70.5.1233.bloodjournal7051233
- Boyd AW, Metcalf D. Induction of differentiation in HL60 leukaemic cells: a cell cycle dependent all-or-none event. Leuk Res. 1984;8(1):27–43. doi:https://doi.org/10.1016/0145-2126(84)90029-8
- Tarella C, Ferrero D, Gallo E, Pagliardi GL, Ruscetti FW. Induction of differentiation of HL-60 cells by dimethyl sulfoxide: evidence for a stochastic model not linked to the cell division cycle. Cancer Res. 1982;42:445–9.
- Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982;204(3):713–9. doi:https://doi.org/10.1042/bj2040713
- Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 1998;58:3163–72.
- Arai T, Endo N, Yamashita K, Sasada M, Mori H, Ishii H, Hirota K, Makino K, Fukuda K. 6-formylpterin, a xanthine oxidase inhibitor, intracellularly generates reactive oxygen species involved in apoptosis and cell proliferation. Free Radic Biol Med. 2001;30(3):248–59. doi:https://doi.org/10.1016/S0891-5849(00)00465-2
- Arroyo A, Modrianský M, Serinkan FB, Bello RI, Matsura T, Jiang J, Tyurin VA, Tyurina YY, Fadeel B, Kagan VE, et al. NADPH oxidase-dependent oxidation and externalization of phosphatidylserine during apoptosis in Me2SO-differentiated HL-60 cells. Role in phagocytic clearance. J Biol Chem. 2002;277(51):49965–75. doi:https://doi.org/10.1074/jbc.M204513200
- Levy R, Rotrosen D, Nagauker O, Leto TL, Malech HL. Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J Immunol. 1990;145:2595–601.
- Friedman AD. Transcriptional control of granulocyte and monocyte development. Oncogene. 2007;26(47):6816–28. doi:https://doi.org/10.1038/sj.onc.1210764
- Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265(5178):1573–7. doi:https://doi.org/10.1126/science.8079170
- Zhang D-E, Zhang P, Wang N-d, Hetherington CJ, Darlington GJ, Tenen DG. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A. 1997;94(2):569–74. doi:https://doi.org/10.1073/pnas.94.2.569
- Raich N, Romeo PH. Erythroid regulatory elements. Stem Cells. 1993;11(2):95–104. doi:https://doi.org/10.1002/stem.5530110204
- Filmus J, Buick RN. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells. Cancer Res. 1985;45:822–5.
- Komada F, Nishikawa M, Uemura Y, Morita K, Hidaka H, Shirakawa S. Expression of three major protein kinase C isozymes in various types of human leukemic cells. Cancer Res. 1991;51:4271–8.
- Marcinkowska E, Więdłocha A, Radzikowski C. 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem Biophys Res Commun. 1997;241: 419–26. doi:https://doi.org/10.1006/bbrc.1997.7832
- Miranda MB, McGuire TF, Johnson DE. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia. 2002;16(4):683–92. doi:https://doi.org/10.1038/sj.leu.2402400
- Kim S-H, Cho S-S, Simkhada J-R, Lee H-J, Kim S-W, Kim T-S, Yoo J-C. Enhancement of 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced HL-60 leukemia cell differentiation by Panax ginseng. Biosci Biotechnol Biochem. 2009;73(5):1048–53. doi:https://doi.org/10.1271/bbb.80823
- Karlsson-Rosenthal C, Millar JB. Cdc25: mechanisms of checkpoint inhibition and recovery. Trends Cell Biol. 2006;16(6):285–92. doi:https://doi.org/10.1016/j.tcb.2006.04.002
- Okuma E, Inazawa Y, Saeki K, Yuo A. Potential roles of extracellular signal-regulated kinase but not p38 during myeloid differentiation of U937 cells stimulated by cytokines: augmentation of differentiation via prolonged activation of extracellular signal-regulated kinase. Exp Hematol. 2002;30(6):571–81. doi:https://doi.org/10.1016/S0301-472X(02)00801-9
- Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, et al. A comprehensive review on MAPK: A promising therapeutic target in Cancer. Cancers (Basel). 2019;11(10):1618. doi:https://doi.org/10.3390/cancers11101618
- Summy JM, Qian Y, Jiang B-H, Guappone-Koay A, Gatesman A, Shi X, Flynn DC. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src. J Cell Sci. 2003;116(12):2585–98. doi:https://doi.org/10.1242/jcs.00466
- Staser K, Park S-J, Rhodes SD, Zeng Y, He YZ, Shew MA, Gehlhausen JR, Cerabona D, Menon K, Chen S, et al. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk. J Clin Invest. 2013;123(1):329–34. doi:https://doi.org/10.1172/JCI66167
- Zhang Y, Morgan MJ, Chen K, Choksi S, Liu ZG. Induction of autophagy is essential for monocyte-macrophage differentiation. Blood. 2012;119(12):2895–905. doi:https://doi.org/10.1182/blood-2011-08-372383
- Mark Welch DB, Jauch A, Langowski J, Olins AL, Olins DE. Transcriptomes reflect the phenotypes of undifferentiated, granulocyte and macrophage forms of HL-60/S4 cells. Nucleus. 2017;8(2):222–37. doi:https://doi.org/10.1080/19491034.2017.1285989
- Birnie GD. The HL60 cell line: a model system for studying human myeloid cell differentiation. Br J Cancer Suppl. 1988;9:41–5.
- Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4(5):E131–6. doi:https://doi.org/10.1038/ncb0502-e131
- Nishioka C, Ikezoe T, Yang J, Yokoyama A. Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D(3). Leukemia. 2009;23(11):2171–3. doi:https://doi.org/10.1038/leu.2009.152
- Assi R, Ravandi F. FLT3 inhibitors in acute myeloid leukemia: Choosing the best when the optimal does not exist. Am J Hematol. 2018;93(4):553–63. doi:https://doi.org/10.1002/ajh.25027
- Wang Q, Wang X, Studzinski GP. N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3. J Cell Biochem. 2003;89(6):1087–101. doi:https://doi.org/10.1002/jcb.10595